Includes responsibilities relating to prescribing, issuing prescriptions, authorising administration and writing a chart instruction plus special restrictions that relate to ovulatory stimulants, retinoids, prostaglandins, thalidomide and lenalidomide.
Details
- Topic
- Policies and guidelines
- Date published
- 10 Jun 2021
- Size
- 7 pages
- Author
- Department of Health
- Update frequency
- Annual
- Available format
- DOCX
Reviewed 11 June 2021